Happtique and Kessler Foundation lead new working group of application developer... ( West Orange NJ. (December 10 2012) ...)

Happtique and Kessler Foundation lead new working group of application developers alliance

Date:12/11/2012

West Orange, NJ. (December 10, 2012) The Application Developers Alliance has launched a working group focused on health and medical apps. Comprised of Alliance members, the group will support growth in the medical, health, and wellness application marketplace. The working group, chaired by Happtique and Kessler Foundation, will provide core expertise and guidance to the Alliance and its members through commissioned research, white papers, policy recommendations, and best practices.

"Health and medical apps offer a tremendous opportunity for the democratization of health care services. The Alliance looks forward to working with industry leaders through our Health and Medical Apps Working Group to advance these innovations that help make health care more streamlined, cost-efficient, and user-friendly," said Jon Potter, Alliance President.

Happtique, a secure digital platform for curating, certifying, and prescribing mobile health apps, will chair the working group; and Kessler Foundation, a leader in rehabilitation research in mobility and cognition will serve as Vice Chair. "With experts predicting that 30% of Smartphone users will use health and wellness apps by 2015, it is essential that providers and payers have a robust mhealth app marketplace from which they can create app formularies that address their needs," said Ben Chodor, Chief Executive Officer at Happtique.

"The development of the Health and Medical Apps Working Group is timely," said neuropsychologist Denise Krch, PhD. "With more than 13,000 health-related apps available in the consumer market, there is a tremendous need for ambassadorship to this burgeoning field of technology. As a research scientist representing Kessler Foundation, I seek to represent health care providers and act as a steward for consumers, ensuring that advancements made are safe and efficacious. The application of new technologies to rehabilitation research is a priority for Kessler Foundation,
'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

0

GOOD

Post Your Comments:

(Date:7/31/2014)... Perhaps some people are unaware of getting ... from the first day when we were born on earth. ... during their whole life. Some people may live without children ... is not necessary for people to worry about that. A ... a famous China automobile manufacturer , is one of ...

(Date:7/31/2014)... 31, 2014 Updox, the industry ... announces the release of a “Twelve Questions to Ask When ... that are evaluating Health Information Service Providers (HISPs) for Direct ... utilize MEDITECH and Epic electronic health records (EHRs) need to ... of care using the Direct protocol. , “Selecting ...

(Date:7/31/2014)... Daily Gossip reveals in its review that the Flat ... weight loss tips. , The author of the new ... simple to implement. Users don’t have to worry, as they ... start counting calories. , The Flat Belly Forever program ... 12 weeks weight loss program to help sufferers model the ...

(Date:7/31/2014)... USHIO America’s Solid State Lighting ... lighting marketplaces, today announced the launch of its ... users to transform existing, inefficient lamp-based downlights to ... USHIO America’s Uphoria LED downlight retrofit kits fit ... the user to upgrade old incandescent recessed lighting ...

(Date:7/31/2014)... Thanks to its mildly sweet ... long been used as a medium for delivery ... fruit. However consistent, dependable sourcing of erythritol often ... food and beverage manufacturers’ increasing needs for reliable, ... GMO-free ErysweetTM Erythritol. , “Erysweet is unique ...

Breaking Medicine News(10 mins):Health News:FodayAuto.com: Do Not Be Afraid of Getting Old 2 Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 2 Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 3 Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 4 Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2 Health News:Steviva Ingredients Launches Erysweet Erythritol 2

[0] FodayAuto.com: Do Not Be Afraid of Getting Old [0] Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging [0] Flat Belly Forever Review Reveals How to Lose Belly Fat Quickly and Naturally [0] USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits [0] Steviva Ingredients Launches Erysweet Erythritol

... Manuscript in March IssueTAMPA, Fla., March 2 ... alfa-2a and ribavirin in patients with chronic hepatitis ... published in the March issue of Gastroenterology, ... Association Institute (AGA Institute). The study showed that ...

... March 2 LCA-Vision Inc. (Nasdaq: ... under the Lasik Plus (R) brand, today announced that members ... James 30th Annual Institutional Investors Conference on Monday, March 9, ... being held at The JW Marriott Grande Lakes Hotel in ...

... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, ... Company has amended the maturity date of its ... (formerly Laurus Master Funds). , On October 31, ... extension of this facility, originally scheduled to mature ...

... to restructure debt -MCLEAN, Va., March 2 Sunrise Senior ... results and operating data for the fourth quarter and the ... webcast Monday, March 2, 2009, at 9:00 a.m. ET, to ... of life for seniors has been Sunrise,s mission since 1981, ...

... Cardiac Science Corporation (Nasdaq: CSCX ), a ... informatics products, announced today that it will release its ... 2009 after the market close. The Company has scheduled ... p.m. Eastern Time. During the call, Cardiac Science ...

... March 2 Alexza Pharmaceuticals, Inc. (Nasdaq: ... Noymer, PhD has been promoted to Vice President, ... position, he will have oversight responsibilities for device ... technology programs.Dr. Noymer joined Alexza in 2006 and ...

Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology LCA-Vision to Present at the Raymond James 30th Annual Institutional Investors Conference Bioniche Revolving Credit Facility Maturity Date Amended Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D

(Date:7/30/2014)... July 30, 2014 Unilife Corporation ("Unilife" or ... developer and supplier of injectable drug delivery systems, ... capacity, R&D, and facilities in response to increasing ... products and services. During the fourth quarter of ... million in capital expenditures and R&D above normal ...

(Date:7/30/2014)... 30, 2014 /PRNewswire-iReach/ -- Transluminal Technologies LLC, a ... company, has announced today that they have received ... Closure Device. Velox CD™ provides a safe and ... femoral procedures. The single size velox CD™ is ... from 5F to 8F. Velox CD™ ...

(Date:7/30/2014)... PISCATAWAY, N.J. , July 30, 2014 InnoPharma, ... for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), ... of agitation and disturbed behaviors in patients with schizophrenia ... of this generic injectable drug, InnoPharma has entered into ... Sandoz Canada will make, use, sell, market ...

Breaking Medicine Technology:Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 2 Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 3 Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 4 Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 5 Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2 InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2

[0] Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers [0] Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device [0] InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada

... a large,randomized clinical trial for patients with newly ... marrow, has,shown that the use of a low ... with lenalidomide (Revlimid ®),is associated with improved survival ... a higher, standard dose of,dexamethasone. The clinical trial ...

... Programs to be Presented, SOUTH SAN FRANCISCO, Calif., ... four posters containing non-clinical data will be,presented at ... Cancer Research (AACR) to be held from April ... are related to multiple oncology,programs at Cytokinetics and ...

Cached Medicine Technology:Low-Dose Steroid Combined With Lenalidomide Prolongs Survival,Compared With High-Dose Steroid for Multiple Myeloma Treatment 2 Low-Dose Steroid Combined With Lenalidomide Prolongs Survival,Compared With High-Dose Steroid for Multiple Myeloma Treatment 3 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7

Low-Dose Steroid Combined With Lenalidomide Prolongs Survival,Compared With High-Dose Steroid for Multiple Myeloma Treatment Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting

Solid 14 mm blades. Dull finish....

Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....

Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....

Open wire style blades allow complete manipulation of the phaco tip inside the eye. Lid control is excellent, exposure is maximized, and the likelihood of positive pressure is reduced....

Medicine Products:

Barraquer Eye Speculum - Solid Blade Temporal Approach Lid Speculum Barraquer Eye Speculum Osher Lid Speculum